Why don’t insurance companies insure diabetic kids?

14 09 2008

The Diabetes Blog

By Allie Beatty

Ed Hinerman, a life insurance specialist with the Hinerman Group, was posed an interesting challenge recently. For years he has successfully found affordable life insurance for many adults with type 1 diabetes, but he had never been asked about life insurance for children with Type 1 diabetes until now.

After speaking with underwriters in the top 40 or so companies, he found a discernible lack of interest due to lack of data. Companies would say that they couldn’t consider someone with type 1 diabetes until they were either age 15 or age 20. A peer in the industry told Ed the knee jerk reaction was because insurance companies haven’t done mortality studies on children. They simply don’t have any data upon which to base the pricing for products. Uh oh!! That coupled with the fact that there really isn’t any financial incentive for them to study and create products for a relatively small market that would produce relatively low premium, kind of sets the tone. Well, now the war has been defined and the battles are becoming clearer.

When Ed contacted the ADA for assistance in this matter – hold your breath (it’s a shocker!) – they turned a cold shoulder on a diabetic’s need. What if the diabetic’s parents were doing what so many families do – and trying to buy a whole life policy to help pay for their kids college someday? It’s really not fair! Here’s where fair begins — Ed asked me to gather some facts it will take to get the insurance companies attention. Does anybody have any idea of the mortality rate of children after being diagnosed with type 1 diabetes?

Bottom line. Life insurance companies make big money and for them to cut and run from children just because it might not make them more big bucks, or because they really haven’t done their homework and aren’t interested in doing it, isn’t acceptable. Game on! I hope we can make a good showing, at the very least – hit one out of the park for the fans. Thanks for inviting me to play, Ed!





Non Invasive glucometer

4 09 2008


Non-invasive Glucometer from OrSense Approved in Europe – Medgadget – www.medgadget.com

The NBM-200G is based on OrSense’s proprietary breakthrough technology that allows non-invasive measurement of analytes including glucose, hemoglobin, and oxygen saturation with very high sensitivity. The NBM-200G is operated by placing a ring-shaped probe around the patient’s finger, which applies a gentle pressure to the finger, similar to that applied during non-invasive blood-pressure measurement and temporarily occludes the blood flow. During the occlusion, optical elements in the sensor perform a sensitive measurement of the light transmitted through the finger. This method, called Occlusion Spectroscopy, provides a quick, accurate and painless measurement of the patient’s blood glucose.








Follow

Get every new post delivered to your Inbox.